Selenium Supplementation of Patients With Cirrhosis

Stopped early · Not applicable · Has a placebo group

Conditions studied: Cirrhosis

In brief

This study is being conducted to determine if patients with cirrhosis (liver disease) are selenium deficient. The effect of supplementation with two chemical forms of selenium on plasma selenium biomarkers will be determined and correlated with the severity of the liver disease.

Key facts

Study ID

NCT00212212

Run by

Vanderbilt University

People needed

99

Starts

2006-03-01

Expected to finish

2012-03-01

Last updated by the study team

2012-03-07

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• adults with cirrhosis

You may not qualify if…

• Pregnancy or planning a pregnancy
• Selenium supplements of 25 µg or more within the past year

Where it is running

• Vanderbilt University — Nashville, Tennessee, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.